M Mascolini, JW Mellors, DD Richman… - Antiviral …, 2011 - ncbi.nlm.nih.gov The XIX International HIV and Hepatitis Virus Drug Resistance Workshop offered scientists, clinical investigators, physicians and others an opportunity to present study results selected in a rigorous peer-review process and to discuss those data in an open forum. In 2010, Workshop ... All 3 versions
P Gripon… - US Patent 7,892,754, 2011 - Google Patents Illllllllllllllllllllllllllllllllllllllllllllllllll US007892754B2 (12) United States Patent Gripon et al. (io) Patent No.: (45) Date of Patent: US 7,892,754 B2 Feb.22, 2011 (54) HEPATITIS B VIRUS PRE-S1 DERIVED SYNTHETIC POLYPEPTIDES AND USES THEREOF (75) Inventors: Philippe Gripon, ... Related articles - All 3 versions
P Gripon… - US Patent App. 13/014,070, 2011 - Google Patents US 2011/0178004 A1 Jul. 21, 2011 invention can be chimeric antibodies, humanized antibodies, or antigen binding fragments. Fab, Fab', F(ab')2 and Fv. They can also be immunoconjugated or labelled antibodies. [0043] Polyclonal antibodies can be obtained from serum of an ...
Q Lin, D Fang, X Hou, Y Le, J Fang… - The Journal of …, 2011 - Am Assoc Immnol The hepatitis C virus (HCV) nonstructural 5A, a phosphorylated zinc metalloprotein, is an essential component of the HCV replication complex. An amphipathic α-helical peptide (HCV peptide [C5A]) derived from nonstructural 5A membrane anchor domain possesses potent ... Cited by 1 - Related articles - All 4 versions
DR Milich… - US Patent 7,883,843, 2011 - Google Patents IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII US007883843B2 (12) United States Patent Milich et al. (io) Patent No.: (45) Date of Patent: US 7,883,843 B2 *Feb. 8, 2011 (54) (63) (51) (52) (58) (56) HEPATITIS VIRUS CORE PROTEINS AS 2003/0099668 Al 5/2003 Bachmann et al. VACCINE ... Related articles - All 4 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
